ARHGEF2 and neoplasm: During tumor metastasis, aberrant GEF–H1 release in breast cancer cells requires microtubule‐severing enzymes like FL2, with activation thresholds strictly regulated by scaffold proteins such as IQGAP1 [136, 137].